Delivery Order SPE2DR25D1004-SPE2DR26FSXT9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,022.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, non-set-aside contract issued under a competitively awarded vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $9,071.48 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count package) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $7,824.25 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of NURTEC ODT 75 MG tablets (8-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 6, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $10,977.91 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on September 15, 2025, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The...
- The Defense Logistics Agency awarded a $5,164.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on December 18, 2025, with an ultimate completion date of December 19, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC...
- The Defense Logistics Agency awarded a $34,561.46 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency awarded a $6,098.66 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count unit) on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $4,254.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 13, 2025, with completion targeted for August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $70,061.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, where the products will...
- The Defense Logistics Agency awarded a $8,118.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 30, 2025, with a completion deadline of December 31, 2025. This non-competed delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSXT9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,311.92 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on January 8, 2026, with completion expected by January 9, 2026. This is a firm fixed-price, non-set-aside contract utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company operates as a major distributor of medications and medical supplies for federal military and healthcare systems. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical vendor in the federal pharmaceutical supply chain, particularly for military healthcare programs and the Defense Health Agency. The company's extensive contract history with DLA demonstrates its capability to fulfill federal procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for NURTEC ODT represents a routine pharmaceutical procurement under the established IDC vehicle that enables efficient fulfillment of government medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 1/7/26 |